Omics Studies in CKD: Diagnostic Opportunities and Therapeutic Potential
PROTEOMICS · 2025-06 · 25 (11-12)
DOI: 10.1002/pmic.202400151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PROTEOMICS, online erschienen am 11.11.2024. Verfasst von Merita Rroji und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Nephrology, University of Medicine Tirana, Tirana, Albania. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Metabolomics, Proteomics, Genomics. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 241 Literaturangaben.
Abstract (Originalsprache)
Omics technologies have significantly advanced the prediction and therapeutic approaches for chronic kidney disease (CKD) by providing comprehensive molecular insights. This is a review of the current state and future prospects of integrating biomarkers into the clinical practice for CKD, aiming to improve patient outcomes by targeted therapeutic interventions. In fact, the integration of genomic, transcriptomic, proteomic, and metabolomic data has enhanced our understanding of CKD pathogenesis and identified novel biomarkers for an early diagnosis and targeted treatment. Advanced computational methods and artificial intelligence (AI) have further refined multi‐omics data analysis, leading to more accurate prediction models for disease progression and therapeutic responses. These developments highlight the potential to improve CKD patient care with a precise and individualized treatment plan .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Department of Nephrology, University of Medicine Tirana, Tirana, Albania.
- Department of Nephrology, University Sts.Cyril and Methodius, Skopje, N.Macedonia.
ORCID-Profile: Merita Rroji
Zitieren
APA
Rroji, M., & Spasovski, G. (2025). Omics Studies in CKD: Diagnostic Opportunities and Therapeutic Potential. PROTEOMICS, 25(11-12). https://doi.org/10.1002/pmic.202400151
Vancouver
Rroji M, Spasovski G. Omics Studies in CKD: Diagnostic Opportunities and Therapeutic Potential. PROTEOMICS. 2025;25(11-12). doi:10.1002/pmic.202400151
BibTeX
@article{Rroji2025,
author = {Rroji, Merita and Spasovski, Goce},
title = {Omics Studies in CKD: Diagnostic Opportunities and Therapeutic Potential},
journal = {PROTEOMICS},
year = {2025},
volume = {25},
number = {11-12},
doi = {10.1002/pmic.202400151}
}
EUVIMED